Cargando…

Myosteatosis as a Shared Biomarker for Sarcopenia and Cachexia Using MRI and Ultrasound

PURPOSE: Establish bedside biomarkers of myosteatosis for sarcopenia and cachexia. We compared ultrasound biomarkers against MRI-based percent fat, histology, and CT-based muscle density among healthy adults and adults undergoing treatment for lung cancer. METHODS: We compared ultrasound and MRI myo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lortie, Jevin, Rush, Benjamin, Osterbauer, Katie, Colgan, T. J., Tamada, Daiki, Garlapati, Sujay, Campbell, Toby C., Traynor, Anne, Leal, Ticiana, Patel, Viharkumar, Helgager, Jeffrey J., Lee, Kenneth, Reeder, Scott B., Kuchnia, Adam J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Rehabilitation Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9397668/ https://www.ncbi.nlm.nih.gov/pubmed/36189019 http://dx.doi.org/10.3389/fresc.2022.896114

Ejemplares similares

Corrigendum: Myosteatosis as a Shared Biomarker for Sarcopenia and Cachexia Using MRI and Ultrasound
por: Lortie, Jevin, et al.
Publicado: (2022)

The effect of computed tomography parameters on sarcopenia and myosteatosis assessment: a scoping review
por: Lortie, Jevin, et al.
Publicado: (2022)

High prevalence of sarcopenia and myosteatosis in patients undergoing hemodialysis
por: Fu, Chen, et al.
Publicado: (2023)

The impact of sarcopenia and myosteatosis on postoperative outcomes in patients with inflammatory bowel disease
por: O’Brien, Stephen, et al.
Publicado: (2018)

Psoriasis Is Associated With Myosteatosis but Not Sarcopenia: A Case-Control Study
por: Chen, Xiaomei, et al.
Publicado: (2021)

Effects of sarcopenia and myosteatosis are alleviated in reduced port surgery for diverticulitis
por: Schaffler-Schaden, Dagmar, et al.
Publicado: (2023)

Editorial: Innovative imaging approaches to advance musculoskeletal rehabilitation
por: Smith, Andrew, et al.
Publicado: (2023)

Combination of DXA and BIS Predicts Jump Power Better Than Traditional Measures of Sarcopenia
por: Rush, Benjamin, et al.
Publicado: (2021)

Prognostic Value of Sarcopenia and Myosteatosis in Patients with Resectable Pancreatic Ductal Adenocarcinoma
por: Kim, Dong Wook, et al.
Publicado: (2022)

Sarcopenia and myosteatosis are accompanied by distinct biological profiles in patients with pancreatic and periampullary adenocarcinomas
por: Stretch, Cynthia, et al.
Publicado: (2018)

Sarcopenia and Myosteatosis at Presentation Adversely Affect Survival After Esophagectomy for Esophageal Cancer
por: Srpcic, Matevz, et al.
Publicado: (2020)

Sarcopenia and Myosteatosis as Prognostic Markers in Patients with Advanced Cholangiocarcinoma Undergoing Palliative Treatment
por: Jördens, Markus S., et al.
Publicado: (2021)

Diagnosing sarcopenia and myosteatosis based on chest computed tomography images in healthy Chinese adults
por: Tan, Lingling, et al.
Publicado: (2021)

Sarcopenia and Myosteatosis Are Associated with Neutrophil to Lymphocyte Ratio but Not Glasgow Prognostic Score in Colorectal Cancer Patients
por: Aro, Raila, et al.
Publicado: (2022)

Aging, Osteo-Sarcopenia, and Musculoskeletal Mechano-Transduction
por: Leser, Jenna M., et al.
Publicado: (2021)

Are Sarcopenia and Myosteatosis in Elderly Patients with Pelvic Ring Injury Related to Mortality, Physical Functioning and Quality of Life?
por: Banierink, Hester, et al.
Publicado: (2021)

Combating sarcopenia in geriatric rehabilitation patients: study protocol of the EMPOWER-GR observational cohort, sarcopenia awareness survey and randomised controlled feasibility trial
por: Verstraeten, Laure MG, et al.
Publicado: (2022)

Relationship between sarcopenia/myosteatosis and frailty in hospitalized patients with cirrhosis: a sex-stratified analysis
por: Feng, Hongjuan, et al.
Publicado: (2021)

Defining sarcopenia and myosteatosis: the necessity for consensus on a technical standard and standardized cut‐off values
por: Westenberg, Lisa B., et al.
Publicado: (2022)

Sarcopenia and myosteatosis diagnostic tool for gastrointestinal cancer: creatinine to cystatin C ratio as evaluation marker
por: Liu, Hao, et al.
Publicado: (2023)

Research on cachexia, sarcopenia and skeletal muscle in cardiology
por: Coats, Andrew J. S.
Publicado: (2012)

Emerging markers of cancer cachexia and their relationship to sarcopenia
por: Lipshitz, Melanie, et al.
Publicado: (2023)

The Journal of Cachexia, Sarcopenia and Muscle in 2019
por: von Haehling, Stephan, et al.
Publicado: (2019)

Impact of sarcopenia and myosteatosis on survival outcomes for patients with head and neck cancer undergoing curative-intent treatment
por: Ahern, Elizabeth, et al.
Publicado: (2023)

Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity
por: Kim, Hong-Kyu, et al.
Publicado: (2023)

Sarcopenia and Myosteatosis Assessed by Magnetic Resonance Enterography May Predict Negative Outcomes in Patients with Crohn’s Disease
por: Eren Cankurtaran, Rasim, et al.
Publicado: (2023)

The Association Between Sarcopenia and Functional Improvement in Older and Younger Patients Who Completed Inpatient Rehabilitation: A Prospective Cohort Study
por: Churilov, Irina, et al.
Publicado: (2021)

Nutrition in the spotlight in cachexia, sarcopenia and muscle: avoiding the wildfire
por: Prado, Carla M., et al.
Publicado: (2020)

The Prognostic Value of Sarcopenia and Myosteatosis in Biliary Tract Cancer After Palliative Treatment With Radiation-Emitting Metallic Stent
por: Chen, Qi, et al.
Publicado: (2022)

Contributory roles of sarcopenia and myosteatosis in development of overt hepatic encephalopathy and mortality after transjugular intrahepatic portosystemic shunt
por: Yin, Liang, et al.
Publicado: (2023)

Moving on up: the Journal of Cachexia, Sarcopenia and Muscle
por: von Haehling, Stephan, et al.
Publicado: (2015)

Shared and Divergent Epigenetic Mechanisms in Cachexia and Sarcopenia
por: Yedigaryan, Laura, et al.
Publicado: (2022)

Kidney function in cachexia and sarcopenia: Facts and numbers
por: Okamura, Masatsugu, et al.
Publicado: (2023)

Improving functional outcomes and quality of life in an elderly woman with sarcopenia and spinal Tuberculosis: A case report
por: Defi, Irma Ruslina, et al.
Publicado: (2023)

Ethical guidelines for authorship and publishing in the Journal of Cachexia, Sarcopenia and Muscle
por: von Haehling, Stephan, et al.
Publicado: (2010)

Myosteatosis rather than sarcopenia associates with non‐alcoholic steatohepatitis in non‐alcoholic fatty liver disease preclinical models
por: Nachit, Maxime, et al.
Publicado: (2020)

Impact of Sarcopenia and Myosteatosis in Non-Cirrhotic Stages of Liver Diseases: Similarities and Differences across Aetiologies and Possible Therapeutic Strategies
por: Cespiati, Annalisa, et al.
Publicado: (2022)

Moving upwards – the journal of cachexia, sarcopenia and muscle in 2016
por: von Haehling, Stephan, et al.
Publicado: (2016)

Oodles of opportunities: the Journal of Cachexia, Sarcopenia and Muscle in 2017
por: von Haehling, Stephan, et al.
Publicado: (2017)

COVID‐19: a major cause of cachexia and sarcopenia?
por: Morley, John E., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_eg44u67bk807slqidap46bi284